Estimating prevalence of type 1 and type 2 diabetes in a population of African Americans with diabetes mellitus

American Journal of Epidemiology

Volumn 149, Issue 1, 1999, Pages 55-63

  Boyle, James P ^a   Engelgau, Michael M ^a   Thompson, Theodore J ^a   Goldschmid, Merilyn G ^a   Beckles, Gloria L ^a   Timberlake, David S ^a   Herman, William H ^b   Ziemer, David C ^c   Gallina, Daniel L ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

Classification; Diabetes mellitus; Logistic models

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; DISEASE CLASSIFICATION; ETHNIC GROUP; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; STATISTICAL MODEL;

EID: 0032962002     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009728     Document Type: Article

References (33)

1. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
2. World Health Organization Expert Committee on Diabetes Mellitus. Second report on diabetes melilitus. Geneva, Switzerland: World Health Organization, 1989:8-14. (WHO technical report series 646).
3. Prior MJ, Prout T, Miller D, et al. C-peptide and the classification of diabetes mellitus in patients in the Early Treatment Diabetic Retinopathy Study. Report number 6. Ann Epidemiol 1993;3:9-17.
4. Welborn TA, Garcia-Webb P, Bonser AM. Basal C-peptide in the discrimination of type I and type II diabetes. Diabetes Care 1981;4:616-19.
5. Hother-Nielsen O, Faber O, Schwartz N, et al. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 1988;11:531-7.
6. Klein R, Klein BE, Moss SE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes 1995;44:796-801.
7. Landin-Ollson M, Nilsson KO, Lernmark A, et al. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 1990;33:561-8.
8. Katzeff HL, Savage PJ, Barclay-White B, et al. C-peptide measurement in the differentiation of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1985;28:264-8.
9. Harris MI, Cowie CC, Howie LJ. Self-monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care 1993;16:1116-23.
10. Harris MI, Robbins DC. Prevalence of adult-onset IDDM in the U.S. population. Diabetes Care 1994;17:1337-40.
11. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes Epidemiology Research International Group. Diabetes 1988;37:1113-19.
12. Lipman TH. The epidemiology of type 1 diabetes in children 0-14 years of age in Philadelphia. Diabetes Care 1993;16:922-5.
13. Tull ES, Roseman JM, Christian CLE. Epidemiology of childhood IDDM in the U.S. Virgin Islands from 1979 to 1988. Diabetes Care 1991;14:558-64.
14. LaPorte RE, Matsushima M, Chang YF. Prevalence and incidence of insulin-dependent diabetes. In: Harris MI, Cowie CC, Stern MP, et al, eds. Diabetes in America. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995:37-46. (NIH publication no. 95-1468).
15. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin-dependent diabetes. In: Harris MI, Cowie CC, Stern MP, et al, eds. Diabetes in America. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995:47-67. (NIH publication no. 95-1468).
16. Umpierrez GE, Casals MMC, Gebhart SSP, et al. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995; 44:790-5.
17. Banerji MA, Chaiken RL, Huey H, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994;43:741-5.
18. Tull ES, Roseman JM. Diabetes in African Americans. In: Harris MI, Cowie CC, Stern MP, et al, eds. Diabetes in America. Bethesda, MD: National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases, 1995:613-30. (NIH publication no. 95-1468).
19. Stern MP, Mitchell BD. Diabetes in Hispanic Americans. In: Harris MI, Cowie CC, Stern MP, et al, eds. Diabetes in America. Bethesda, MD: National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases, 1995:631-60. (NIH publication no. 95-1468).
20. Rogan WJ, Gladen B. Estimating prevalence from the results of a screening test. Am J Epidemiol 1978;107:71-6.
21. Ziemer DC, Goldschmid MG, Musey VC, et al. Diabetes in urban African Americans. III. Management of type II diabetes in a municipal hospital setting. Am J Med 1996;101:25-33.
22. American Diabetes Association. Guide to diagnosis and classification of diabetes mellitus and other categories of glucose tolerance. Diabetes Care 1997;20(suppl):21.
23. Chambers JM, Hastie TJ. Statistical models in S. Pacific Grove, CA: Wadsworth & Brooks, 1992.
24. Collet D. Modelling binary data. London, England: Chapman & Hall, 1991.
25. Schwarz G. Estimating the dimension of a model. Ann Stat 1978;6:461-4.
26. McNeil BJ, Keeler E, Adelstein SJ. Primer on certain elements of medical decision making. N Engl J Med 1975;293:211-15.
27. Joffe BI, Panz VR, Wing JR. et al. Pathogenesis of non-insulin-dependent diabetes mellitus in the black population of southern Africa. Lancet 1992;340:460-2.
28. DCCT Research Group. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 1987;65:30-6.
29. Rewers M, Hamman RF. Risk factors for non-insulin-dependent diabetes. Diabetes in America. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995:179-220. (NIH publication no. 95-1468).
30. Umpierrez GE, Casals MM, Gebhart SS, et al. Diabetic ketoacidosis in obese African Americans. Diabetes 1995;44:790-5.
31. Banerji MA, Lebovitz HE. Insulin-sensitive and insulin-resistant variants in NIDDM. Diabetes 1989;38:784-92.
32. Service FJ, Rizza RA, Zimmerman BR, et al. The classification of diabetes by clinical and C-peptide criteria. Diabetes Care 1997;20:198-201.
33. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care 1987;10:1-19.